The costly winter pet mistakes Australians are making
MELBOURNE, Australia, July 28, 2026 /PRNewswire/ -- As cost-of-living pressures bite, Petstock is warning pet parents not to overlook subtle winter health changes, which can lead to vet bills of up to $15,600 if left untreated. Dog snuggled up with Buddy toy next to fireplace in winter Australians spend more than $1.9 billion on veterinary...
Everest Medicines Announces Participation in Upcoming Investor Conferences
SHANGHAI, July 27, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that Ian Woo, President and Chief Financial Officer, will participate in the upcoming investor conferences. Morgan Stanley Biotech Without Borders SeriesDate: Tuesday, July 28, 2026Time: US: 10:00am...
TriNetX Appoints August Calhoun Chief Executive Officer
Jeff Margolis Resumes Chairman Role as Company Completes CEO Transition CAMBRIDGE, Mass., July 27, 2026 /PRNewswire/ -- TriNetX, The Global Truth Engine for Better Human Health™ and operator of the world's leading federated health data network, today announced the appointment of August Calhoun as Chief Executive Officer, effective immediately. Jeff Margolis,...
HoneyNaps Registers as Contract Research Organization (CRO), Accelerating AI-Powered Clinical Trial Analytics
Strengthens specialized AI-powered sleep data analysis services for global pharmaceutical, medical device, and healthcare companies Targets the rapidly growing global sleep clinical research market with advanced biomarker analytics and continual learning technology Leverages experience from clinical studies involving more than 10,000 participants to support global multicenter trials BOSTON, July 27, 2026 /PRNewswire/ -- HoneyNaps, today announced...
AsymBio Kicks Off Construction of Fengxian R&D Building to Establish a Full-Lifecycle, One-Stop Biologics Service Ecosystem
SHANGHAI, July 27, 2026 /PRNewswire/ -- AsymBio, a biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary of Asymchem Group (stock codes: 002821.SZ / 6821.HK), today announced that construction of its new R&D building has officially broken ground at the Shanghai Fengxian site. The project marks a pivotal infrastructure step in strengthening AsymBio's...
Seegene Proposes Comprehensive Reproductive Tract Infection Testing Approach through the Global Million Clinical Study (GMCS)
STAgora™ analysis of approximately 60,000 test results collected over 42 months showed that STI pathogens were detected in 82% of HPV-positive cases Findings support the potential value of a comprehensive testing approach that provides both HPV and STI pathogen information Seegene to validate the clinical utility of comprehensive HPV &...
Pictor Debuts New PictImager® at ADLM 2026 to Make Targeted Protein Analysis More Practical
Beta-site engagement begins as Pictor introduces an integrated 96-well workflow designed for scalable targeted protein analysis in research laboratories. CARLSBAD, Calif., July 27, 2026 /PRNewswire/ -- Pictor Holdings Inc., a global targeted proteomic platform company, today announced the public debut of its next-generation high-resolution platform at ADLM 2026, highlighted by the...
Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity and Reaffirms Strategic Focus on Global Licensing Partnerships
TAIPEI, July 27, 2026 /PRNewswire/ -- Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics, today reaffirmed its strategic focus on pursuing global licensing partnerships to address the growing medical needs in the urology sector. Building upon the momentum of its recent participation...
Waters Launches Industry’s Most Sensitive and Robust Clinical IVD System with Xevo TQ Absolute XR IVD Mass Spectrometer
Brings Xevo™ TQ Absolute XR Mass Spectrometer's industry-leading tandem quadrupole MS sensitivity to clinical applications across women's health, cancer assessment, and toxicology. Offers 5x greater sensitivity vs. in-class instruments with lower detection limits in smaller sample volumes, introducing a step-change in analytical performance for complex biological matrices. Up to six-fold...
Insilico Medicine Announces Oral Presentation at ESMO 2026 for Phase 1 Clinical Study of ISM6331 in Mesothelioma and Advanced Solid Tumors
Presentation to feature first-in-human results for ISM6331, a novel, AI-designed pan-TEAD inhibitor targeting the Hippo pathway Global Phase 1 multicenter study evaluates safety, tolerability, and preliminary efficacy in patients with mesothelioma and other advanced solid tumors CAMBRIDGE, Mass., July 27, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", HKEX:3696), a clinical-stage, generative AI-driven drug discovery company, today announced that first-in-human...
